Evidence map›Paper›PMID 27198545›Full record

Observational studyBMC infectious diseases2016

Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012).

Alberto L García-Basteiro, Durval Respeito, Orvalho J Augusto, Elisa López-Varela, Charfudin Sacoor, Victor G Sequera, Aina Casellas, Quique Bassat, Ivan Manhiça, Eusebio Macete and 2 more

Erratum issuedOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Within-host evolution of drug tolerance inJAC-antimicrobial resistance · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali.Journal of clinical tuberculosis and other mycobacterial diseases · 2019
    Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Alberto L García-BasteiroCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique. alberto.garcia-basteiro@manhica.net.
Durval RespeitoCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Orvalho J AugustoCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Elisa López-VarelaCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Charfudin SacoorCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Victor G SequeraISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Aina CasellasISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Quique BassatCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Ivan ManhiçaMinistry of Health, National Tuberculosis Program, Maputo, Mozambique.
Eusebio MaceteISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Frank CobelensAmsterdam Institute for Global Health and Development, Academic Medical Centre, Amsterdam, The Netherlands.
Pedro L AlonsoCentro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Manhiça Health Research Centre · MZBarcelona Institute for Global Health · ESUniversitat de Barcelona · ESAmsterdam Institute for Global Health and Development · NLMinistry of Health · MZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Mozambique, there is limited data regarding the monitoring of Tuberculosis (TB) treatment results and determinants of adverse outcomes under routine surveillance conditions. The objectives of this study were to evaluate treatment outcomes among TB patients, analyze factors associated with a fatal outcome and determine the proportion of deaths attributable to TB in the district of Manhiça, Southern Mozambique.

methodsThis is a retrospective observational study based on TB patients diagnosed in the period 2011-2012. We used three different data sources: a) TB related variables collected by the National TB Control Program in the district of Manhiça for all TB cases starting treatment in the period 2011-2012. b) Population estimates for the district were obtained through the Mozambican National Statistics Institute. c) Deaths and other relevant demographic variables were collected from the Health and Demographic Surveillance System at Manhiça Health Research Center. WHO guidelines were used to define TB cases and treatment outcomes.

resultsOf the 1957 cases starting TB treatment in the period 2011-2012, 294 patients (15.1 %) died during anti-tuberculous treatment. Ten per cent of patients defaulted treatment. The proportion of patients considered to have treatment failure was 1.1 %. HIV infection (OR 2.73; 95 % CI: 1.70-4.38), being male (OR: 1.39; 95 % CI 1.01-1.91) and lack of laboratory confirmation (OR: 1.54; 95 % CI 1.12-2.13) were associated with dying during the course of TB treatment (p value <0.05). The contribution of TB to the overall death burden of the district for natural reasons was 6.5 % (95 % CI: 5.5-7.6), higher for males than for females (7.8 %; 95 % CI: 6.1-9.5 versus 5.4 %; 95 % CI: 4.1-6.8 respectively). The age group within which TB was responsible for the highest proportion of deaths was 30-34 among males and 20-24 among females (20 % of all deaths in both cases).

conclusionThis study shows a very high proportion of fatal outcomes among TB cases starting treatment. There is a high contribution of TB to the overall causes of mortality. These results call for action in order to improve TB (and TB/HIV) management and thus treatment outcomes of TB patients.

Indexed as

AdolescentAdultCoinfectionFemaleHIV InfectionsHumansMaleMiddle AgedMozambiqueRetrospective StudiesSurvival AnalysisTreatment OutcomeTuberculosisYoung AdultAdverse outcomeDeathManhiçaMortalityTuberculosis

Identifiers

PMID27198545
PMCPMC4874028
OpenAlexW2398953119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.